Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Milwaukee › NPI 1427271378
Physician

Aurora Medical Group, INC.

Aurora Medical Group, INC. was paid $139.24M by Medicaid between Jan 2018 and Dec 2024, across 573 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.

33Billing provider infoAURORA MEDICAL GROUP, INC.
MILWAUKEE, WI 53215
33aNPI1427271378assigned 04/10/2007
28Total paid$139.24M
24GClaims5,067,639
24DCodes billed573
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Internal Medicine Physician providers in Wisconsin

Rank by total paid#1 of 160
Median peer was paid$6K
This provider vs. median23,322×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018585,078$15.99M
2019614,975$16.03M
2020568,259$15.03M
2021846,954$22.04M
2022869,042$22.75M
2023959,126$25.28M
2024incomplete624,205$22.13M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 22% 839,809 763,289 $30.77M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 589,155 540,318 $16.24M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.7% 204,247 191,762 $7.95M
76819 Fetal biophysical profile; without non-stress testing 3.1% 49,626 26,524 $4.31M
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient 2.9% 111,669 75,058 $3.97M
90792 Psychiatric diagnostic evaluation with medical services 2.3% 33,747 28,182 $3.20M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.2% 52,694 48,838 $3.06M
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 2.1% 15,112 14,121 $2.96M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 2.1% 37,306 31,984 $2.93M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.0% 66,186 61,725 $2.74M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.9% 46,467 45,059 $2.71M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 51,514 48,172 $2.43M
561 more codes
99233 Hospital visit by a doctor, follow-up day (complex) 1.7% 99,678 $2.33M
70450 Computed tomography, head or brain; without contrast material 1.6% 75,670 $2.22M
99215 Doctor's office visit, returning patient (complex) 1.3% 41,367 $1.87M
99232 Hospital visit by a doctor, follow-up day 1.3% 132,186 $1.85M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 41,841 $1.76M
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.1% 10,643 $1.48M
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 1.0% 16,827 $1.42M
99203 Doctor's office visit, new patient (routine) <1% 27,432 $1.32M
99239 Hospital discharge day management, more than 30 minutes <1% 22,579 $1.27M
99223 Prolong inpt eval add15 m <1% 25,503 $1.24M
71045 Radiologic examination, chest; single view <1% 270,039 $1.22M
99283 Emergency room visit (moderate) <1% 39,965 $1.11M
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 184,926 $1.04M
99000 <1% 285,157 $1.04M
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 33,087 $1.01M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 17,325 $1.01M
77067 Screening mammography, bilateral, including computer-aided detection <1% 24,633 $1000K
76801 <1% 7,883 $974K
71046 Radiologic examination, chest; 2 views <1% 93,693 $930K
J2357 Injection, omalizumab, 5 mg <1% 720 $896K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 35,498 $762K
99204 Doctor's office visit, new patient (more involved) <1% 11,979 $749K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 16,756 $683K
98941 Chiropractic manipulative treatment; spinal, 3-4 regions <1% 39,342 $662K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 6,797 $629K
76821 <1% 7,228 $537K
90686 <1% 65,273 $534K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 13,048 $525K
71275 Computed tomographic angiography, chest, with contrast material <1% 11,116 $498K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 20,481 $488K
59025 Fetal non-stress test <1% 10,428 $472K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 67,912 $457K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 2,694 $413K
0240U <1% 12,945 $411K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 13,688 $406K
76813 <1% 4,532 $399K
90837 Psychotherapy session, about an hour <1% 6,299 $391K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 9,016 $389K
80053 Comprehensive metabolic panel <1% 43,163 $388K
76820 <1% 9,981 $378K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 7,185 $369K
99183 <1% 4,159 $367K
99244 Office or other outpatient consultation, moderate to high complexity <1% 4,764 $340K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 5,049 $334K
99243 <1% 5,764 $328K
93356 <1% 19,405 $313K
95886 <1% 5,712 $293K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 4,040 $287K
99443 <1% 17,335 $275K
72125 Computed tomography, cervical spine; without contrast material <1% 6,525 $271K
76830 Ultrasound, transvaginal <1% 6,633 $267K
70551 Magnetic resonance imaging, brain; without contrast material <1% 5,077 $264K
95720 <1% 2,422 $261K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 9,310 $260K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 18,310 $259K
3008F <1% 29,239 $245K
77063 Screening digital breast tomosynthesis, bilateral <1% 20,400 $243K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 4,079 $239K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 5,823 $224K
91322 <1% 2,203 $224K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 10,306 $219K
99220 <1% 4,589 $215K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,476 $210K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 8,529 $195K
99460 <1% 1,984 $191K
76642 <1% 8,252 $187K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 3,470 $185K
0001A <1% 5,744 $185K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 5,589 $183K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,922 $179K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 10,494 $177K
71250 <1% 4,179 $177K
90677 <1% 4,230 $176K
99238 Hospital discharge day management, 30 minutes or less <1% 6,630 $171K
98942 <1% 8,985 $168K
73630 <1% 11,299 $163K
93000 <1% 13,777 $159K
0002A <1% 4,375 $156K
80050 General health panel <1% 4,749 $156K
70496 <1% 2,630 $152K
74018 <1% 21,656 $146K
11721 <1% 12,813 $142K
99253 <1% 2,745 $141K
90791 Psychiatric diagnostic evaluation <1% 1,943 $137K
93793 <1% 32,743 $136K
76825 <1% 1,070 $136K
70498 <1% 2,222 $129K
01967 Neuraxial labor analgesia/anesthesia for planned vaginal delivery <1% 1,205 $128K
73562 <1% 8,322 $118K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,058 $117K
99222 Initial hospital care, per day, moderate complexity <1% 2,838 $110K
93295 <1% 4,808 $109K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,253 $108K
90670 <1% 23,765 $108K
72100 <1% 6,651 $107K
93296 <1% 9,170 $106K
90832 Psychotherapy session, about 30 minutes <1% 3,598 $106K
97597 <1% 6,451 $105K
80048 Basic metabolic panel (calcium, ionized) <1% 14,845 $105K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 5,969 $104K
0124A <1% 3,049 $100K
90723 <1% 17,283 $99K
90847 Family psychotherapy with the patient present, 50 minutes <1% 2,360 $98K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,804 $97K
99152 <1% 5,336 $96K
93308 <1% 6,450 $96K
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg <1% 161 $95K
0012A <1% 2,665 $94K
93325 <1% 8,645 $94K
90647 <1% 14,280 $93K
0011A <1% 3,110 $92K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 7,629 $87K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 1,639 $84K
64483 <1% 705 $83K
91321 <1% 1,541 $82K
73610 <1% 5,070 $81K
95913 <1% 683 $81K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,303 $80K
80305 <1% 10,246 $79K
90480 <1% 2,827 $77K
93971 <1% 4,218 $75K
99226 <1% 2,743 $75K
76376 <1% 10,926 $75K
81001 <1% 26,402 $73K
99442 <1% 6,574 $73K
87210 <1% 14,293 $72K
94010 <1% 3,267 $71K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 215 $70K
73221 <1% 1,409 $70K
0071A <1% 2,034 $70K
85027 <1% 12,027 $68K
90961 <1% 1,022 $66K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,466 $65K
90680 <1% 10,131 $64K
99205 Prolong outpt/office vis <1% 884 $63K
77066 Tomosynthesis, mammo <1% 2,016 $63K
78815 Positron emission tomography (PET) for limited area imaging <1% 886 $62K
73030 <1% 5,276 $62K
99217 <1% 2,458 $61K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,562 $61K
81025 <1% 7,970 $61K
92567 <1% 4,490 $60K
76770 <1% 1,339 $60K
98940 <1% 4,722 $58K
20610 <1% 1,582 $56K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 121 $54K
0072A <1% 1,538 $54K
90656 <1% 2,991 $52K
36416 <1% 22,548 $52K
0054A <1% 1,514 $51K
J1729 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg <1% 86 $51K
72141 <1% 604 $47K
0064A <1% 1,521 $47K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 223 $47K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 916 $46K
99242 <1% 1,099 $46K
90853 Group psychotherapy (other than of a multiple-family group) <1% 2,560 $44K
0051A <1% 1,308 $43K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,779 $43K
99225 <1% 2,352 $42K
49083 <1% 325 $42K
73110 <1% 2,149 $42K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 547 $42K
93016 <1% 3,287 $41K
77062 <1% 939 $40K
0134A <1% 1,223 $40K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,824 $39K
99245 <1% 425 $39K
76818 <1% 283 $38K
84443 Thyroid stimulating hormone (TSH) <1% 4,379 $37K
73130 <1% 2,910 $37K
94060 <1% 1,255 $36K
95951 <1% 480 $36K
0004A <1% 1,039 $36K
90960 End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits <1% 496 $35K
83036 Hemoglobin; glycosylated (A1C) <1% 6,057 $34K
80061 Lipid panel <1% 4,376 $33K
36415 Collection of venous blood by venipuncture <1% 61,465 $32K
77065 Tomosynthesis, mammo <1% 1,322 $32K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,727 $32K
77080 <1% 1,426 $31K
J2786 Injection, reslizumab, 1 mg <1% 14 $31K
93975 <1% 466 $31K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 1,141 $30K
85610 <1% 10,125 $29K
0052A <1% 849 $29K
90633 <1% 5,114 $28K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 505 $28K
93970 <1% 773 $27K
76536 <1% 919 $27K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 96 $27K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 303 $27K
95910 <1% 418 $26K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,337 $26K
81003 <1% 14,788 $26K
0111A <1% 860 $26K
93018 <1% 2,956 $26K
64493 <1% 270 $24K
80076 <1% 3,488 $24K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 3,001 $24K
93015 <1% 567 $24K
99254 <1% 407 $24K
92557 <1% 954 $24K
95117 <1% 5,744 $23K
93321 <1% 5,648 $23K
99188 <1% 1,878 $22K
95012 <1% 1,934 $22K
31231 <1% 525 $22K
99221 <1% 614 $22K
31575 <1% 308 $22K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,287 $22K
82247 <1% 4,365 $21K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,084 $21K
76827 <1% 308 $21K
73140 <1% 1,251 $20K
71271 <1% 453 $19K
93351 <1% 250 $19K
78492 <1% 98 $19K
62323 <1% 248 $18K
92015 Determination of refractive state <1% 3,397 $18K
84702 <1% 2,195 $18K
0112A <1% 525 $18K
96127 <1% 4,351 $17K
93922 <1% 542 $17K
64635 <1% 92 $17K
99219 <1% 419 $17K
82248 <1% 3,553 $17K
82950 <1% 3,555 $16K
85018 <1% 6,935 $16K
0154A <1% 436 $16K
0031A <1% 453 $16K
73502 <1% 1,246 $15K
81513 <1% 359 $15K
77061 <1% 298 $14K
97535 Self-care/home management training, each 15 minutes <1% 691 $14K
95718 <1% 173 $14K
92201 <1% 818 $13K
27096 <1% 129 $13K
84703 <1% 1,832 $13K
90688 <1% 1,006 $13K
85652 <1% 5,661 $13K
69799 <1% 14 $13K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,403 $13K
81002 <1% 6,010 $13K
51798 <1% 2,165 $12K
54150 <1% 233 $12K
92133 <1% 899 $12K
11056 <1% 748 $12K
11057 <1% 561 $11K
69210 <1% 1,169 $11K
87081 <1% 2,569 $11K
82565 <1% 2,827 $11K
93880 <1% 244 $11K
99310 Prolong nursin fac eval 15m <1% 593 $11K
87338 <1% 854 $11K
83690 <1% 1,905 $11K
87563 <1% 615 $10K
82947 <1% 2,680 $10K
84484 <1% 1,008 $10K
87481 <1% 473 $10K
84460 <1% 2,389 $10K
82728 <1% 1,507 $10K
90651 <1% 904 $10K
92083 <1% 804 $10K
64615 <1% 168 $9K
93040 <1% 1,239 $9K
84439 <1% 1,929 $9K
93294 <1% 903 $9K
70486 <1% 190 $9K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 2,438 $9K
99441 <1% 1,242 $8K
V5266 Battery for use in hearing device <1% 731 $8K
64494 <1% 191 $8K
96156 <1% 149 $8K
91200 <1% 1,092 $8K
0121A <1% 235 $8K
76506 <1% 283 $8K
94726 <1% 1,167 $8K
83655 <1% 810 $8K
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) <1% 226 $7K
84450 <1% 1,901 $7K
99307 <1% 498 $7K
83735 <1% 1,707 $7K
17110 <1% 412 $7K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 266 $7K
80081 <1% 171 $7K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 105 $7K
59409 Vaginal delivery only (with or without episiotomy and/or forceps) <1% 12 $7K
82607 <1% 854 $7K
20553 <1% 372 $6K
94729 <1% 1,268 $6K
82962 <1% 2,378 $6K
0074A <1% 161 $6K
0164A <1% 180 $6K
99308 Subsequent nursing facility care, per day, straightforward <1% 436 $6K
0003A <1% 167 $6K
86140 <1% 1,753 $6K
83550 <1% 1,384 $6K
99462 <1% 191 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 134 $6K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 74 $5K
78264 <1% 182 $5K
72040 <1% 328 $5K
64636 <1% 79 $5K
0053A <1% 165 $5K
20552 <1% 515 $5K
96133 <1% 29 $5K
99070 <1% 499 $5K
92134 <1% 363 $5K
87186 <1% 1,026 $5K
J2785 Injection, regadenoson, 0.1 mg <1% 55 $5K
84550 <1% 1,504 $5K
86762 <1% 558 $5K
76942 <1% 81 $5K
99381 <1% 87 $5K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 3,083 $5K
86308 <1% 1,024 $5K
83540 <1% 1,463 $5K
93282 <1% 234 $5K
82150 <1% 887 $5K
90648 <1% 1,368 $4K
36558 <1% 12 $4K
52000 <1% 65 $4K
82951 <1% 392 $4K
87077 <1% 854 $4K
96116 <1% 80 $4K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 175 $4K
82570 <1% 1,518 $4K
59430 <1% 35 $4K
90681 <1% 1,225 $4K
84481 <1% 412 $4K
96139 <1% 17 $4K
90685 <1% 1,161 $4K
99422 <1% 327 $4K
92579 <1% 129 $4K
86780 <1% 552 $4K
73080 <1% 179 $4K
92587 <1% 80 $4K
82746 <1% 451 $4K
22853 <1% 14 $4K
92504 <1% 233 $4K
95874 <1% 383 $4K
87088 <1% 758 $4K
90962 <1% 59 $3K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 469 $3K
95251 <1% 241 $3K
93264 <1% 178 $3K
51741 <1% 92 $3K
87807 <1% 257 $3K
70491 <1% 45 $3K
0013A <1% 84 $3K
92523 <1% 34 $3K
0141A <1% 85 $3K
90746 <1% 43 $3K
90715 <1% 198 $3K
85014 <1% 1,318 $3K
95811 <1% 39 $3K
20611 <1% 70 $3K
92060 <1% 183 $3K
59514 <1% 14 $3K
99236 Prolong inpt eval add15 m <1% 32 $3K
86787 <1% 518 $3K
95912 <1% 28 $3K
99234 <1% 42 $2K
J3535 Drug administered through a metered dose inhaler <1% 847 $2K
75574 <1% 14 $2K
11720 <1% 366 $2K
99385 <1% 43 $2K
76857 <1% 120 $2K
99241 <1% 70 $2K
A9526 Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries <1% 14 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 75 $2K
90672 <1% 88 $2K
94664 <1% 211 $2K
82043 <1% 699 $2K
97161 <1% 55 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 245 $2K
93320 <1% 60 $2K
96158 <1% 52 $2K
74230 <1% 161 $2K
90707 <1% 286 $2K
93304 <1% 30 $2K
0151A <1% 60 $2K
90732 <1% 29 $2K
76937 <1% 263 $2K
99421 <1% 281 $2K
0073A <1% 52 $2K
99252 <1% 46 $2K
86803 <1% 230 $2K
99464 <1% 33 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 169 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 317 $2K
0081A <1% 53 $2K
93926 <1% 42 $2K
99201 <1% 93 $2K
90734 <1% 294 $2K
0399T <1% 5,276 $2K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 95 $2K
82784 <1% 227 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 107 $2K
87480 <1% 157 $2K
87209 <1% 153 $2K
92226 <1% 92 $2K
11100 <1% 48 $2K
96132 <1% 16 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 40 $2K
93925 <1% 41 $2K
0082A <1% 46 $2K
86850 <1% 509 $2K
99235 <1% 13 $2K
77001 <1% 228 $2K
90716 <1% 261 $2K
98927 <1% 49 $2K
73564 <1% 69 $2K
98968 <1% 133 $1K
93750 <1% 59 $1K
92551 <1% 93 $1K
99255 <1% 16 $1K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 80 $1K
99218 <1% 31 $1K
87428 <1% 40 $1K
84156 <1% 712 $1K
87660 <1% 117 $1K
85379 <1% 163 $1K
99173 <1% 67 $1K
78582 <1% 50 $1K
0142A <1% 33 $1K
90710 <1% 194 $1K
90700 <1% 186 $1K
90674 <1% 319 $1K
93272 <1% 53 $1K
43249 <1% 16 $1K
94618 <1% 80 $1K
74022 <1% 69 $1K
82952 <1% 310 $1K
81015 <1% 297 $998.92
74019 <1% 68 $994.88
93042 <1% 228 $986.41
86900 <1% 539 $975.44
86364 <1% 80 $974.87
98928 <1% 32 $957.42
78306 <1% 27 $931.22
43248 <1% 13 $922.67
83880 <1% 29 $920.54
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 42 $903.50
84100 <1% 276 $895.17
87177 <1% 159 $888.12
19083 <1% 12 $867.90
83615 <1% 196 $863.49
93290 <1% 85 $858.96
99349 <1% 12 $840.27
73560 <1% 102 $837.99
92651 <1% 12 $828.60
99384 <1% 14 $806.00
74170 <1% 13 $803.96
11055 <1% 58 $794.59
73090 <1% 52 $761.52
64450 <1% 14 $718.15
84403 <1% 44 $700.00
0083A <1% 22 $690.30
96380 <1% 37 $679.34
87070 <1% 137 $669.42
97166 <1% 17 $637.30
95909 <1% 12 $628.14
G0127 Trimming of dystrophic nails, any number <1% 129 $624.30
84144 <1% 46 $623.03
93352 <1% 31 $613.48
82040 <1% 178 $607.32
64644 <1% 25 $599.76
87205 <1% 311 $599.40
96136 <1% 16 $590.77
93227 <1% 30 $567.47
97165 <1% 15 $563.94
90713 <1% 13 $562.32
87510 <1% 64 $554.62
84132 <1% 180 $544.67
51701 <1% 16 $538.09
73700 <1% 13 $536.32
11102 <1% 12 $529.57
99251 <1% 14 $524.88
64643 <1% 25 $497.93
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 36 $493.87
95819 <1% 26 $490.57
93280 <1% 38 $488.33
73590 <1% 25 $479.54
90696 <1% 51 $476.13
11900 <1% 29 $474.27
84512 <1% 52 $455.75
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 26 $453.52
83516 <1% 64 $428.66
86038 <1% 68 $422.67
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 465 $416.35
96161 <1% 99 $408.86
82670 <1% 32 $370.07
72082 <1% 15 $355.30
73100 <1% 13 $339.29
93451 <1% 12 $335.34
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 17 $331.66
92552 <1% 28 $312.40
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 396 $305.15
84146 <1% 26 $299.76
29540 <1% 13 $297.76
86376 <1% 27 $294.94
93297 <1% 39 $290.60
93244 <1% 30 $267.93
96138 <1% 16 $255.48
83001 <1% 25 $248.38
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 86 $244.50
76882 <1% 14 $202.02
72120 <1% 14 $200.36
83037 <1% 39 $191.48
93298 <1% 19 $188.02
86800 <1% 15 $177.23
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) <1% 22 $177.09
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 12 $176.96
90662 <1% 42 $172.48
74420 <1% 16 $167.35
J1010 Injection, methylprednisolone acetate, 1 mg <1% 32 $158.24
J1030 Injection, methylprednisolone acetate, 40 mg <1% 44 $124.84
83525 <1% 24 $114.53
90785 <1% 52 $104.86
95970 <1% 15 $95.67
87075 <1% 15 $92.98
99306 Prolong nursin fac eval 15m <1% 16 $91.08
86706 <1% 14 $90.63
90687 <1% 27 $89.89
82550 <1% 26 $89.43
97810 <1% 20 $81.07
99091 <1% 14 $78.25
97811 <1% 20 $60.83
20939 <1% 29 $49.37
90744 <1% 14 $46.34
99406 <1% 39 $33.14
81000 <1% 32 $31.98
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 29 $26.16
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 30 $18.32
E0114 Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips <1% 53 $17.10
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 72 $6.79
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 29 $2.45
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 22,010 $0.00
99177 0% 509 $0.00
91313 0% 366 $0.00
91300 0% 1,590 $0.00
91311 0% 242 $0.00
91312 0% 902 $0.00
90630 0% 17 $0.00
91308 0% 40 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 14 $0.00
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 0% 155 $0.00
G0008 Administration of influenza virus vaccine 0% 217 $0.00
91307 0% 371 $0.00
98943 0% 73 $0.00
91305 0% 633 $0.00
91301 0% 877 $0.00
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard 0% 43 $0.00
91306 0% 181 $0.00
91303 0% 34 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 0% 211 $0.00
91315 0% 89 $0.00
99417 Prolong home eval add 15m 0% 27 $0.00
91314 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICHARDSON, KARA (ASSISTANT TREASURER)
Same official

Other billing entities under RICHARDSON, KARA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.